NIH-funded research R01 grant

How the brain protein TTYH1 helps move fats and ApoE in support cells and affects brain aging and Alzheimer’s

Official title: Role of TTYH1 in mobilizing lipids and ApoE in glia: Implications for brain aging and neurodegeneration

Funded at Rutgers the State Univ of Nj Newark · NIH-11307173 · Data updated 2026-11-12

This work looks at how a brain protein called TTYH1 helps move fats and the Alzheimer’s-linked protein ApoE in support cells, which could influence brain aging and memory loss.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers the State Univ of Nj Newark
NIH-funded
Lab location1 site (Newark, United States)
Project startMay 15, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$343,438
NIH project number5R01AG081379-04
Project IDNIH-11307173 on NIH RePORTER

Who could benefit from this research

Could help

People with Alzheimer’s disease, related dementias, or older adults at increased risk could be relevant candidates for sample donation or future trials informed by this research.

Less likely to help

Patients seeking an immediate treatment or clinical therapy would not receive direct clinical benefit from this laboratory-focused project.

What this research studies

From a patient’s perspective, researchers are focusing on a brain protein called TTYH1 and how it helps astrocytes (brain support cells) handle fats and release ApoE, a protein tied to Alzheimer’s risk. They will use human primary astrocytes, gene expression (transcriptomics), and lipid profiling (lipidomics) alongside fruit fly models to see what happens when TTYH1 is missing or altered. Laboratory cell biology experiments will examine autophagy and lipid droplet breakdown in glia and compare findings between healthy and Alzheimer’s-affected samples. The team aims to map the molecular steps linking lipid changes to cell malfunction that could point to future therapeutic targets.

Why it matters

Potential benefit: If successful, this work could reveal new molecular targets for therapies that protect brain cells and slow or prevent Alzheimer’s-related decline.

How similar studies have gone: Previous research links APOE and lipid metabolism to Alzheimer’s, but connecting TTYH1 specifically to ApoE secretion and lipid handling is a newer and less-tested area.

Where this research is happening

  • Rutgers the State Univ of Nj Newark
    Newark, United States
    Active

Researchers

  • Principal investigator: Wong, Ching-on — Rutgers the State Univ of Nj Newark
  • Study coordinator: Wong, Ching-on

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.